Market Overview
Size, regimen adoption, and visible-texture care
- Brevintel analysis values crepey skin treatments at USD 829.2 million in 2026 ($829M), rising to USD 1,429.9 million by 2036 ($1.4B) at a 5.6% CAGR.
- Headline cards list $829M, $1.4B, and 5.6%; coverage is also labeled 2025–2036 while the CAGR card is stated as 5.6% for 2025-2036.
- Demand for crepey skin treatments is projected to expand at 5.6% CAGR between 2026 and 2036, increasing valuation from USD 829.2 million to USD 1,429.9 million.
- Regular neck and body application makes visible-texture care a repeat purchase after regimen adoption.
- UN DESA documented 1.22 billion people aged 60 years or older worldwide in February 2026.
- The mature-consumer pool widens age-focused body-care demand, though uptake still depends on proof and comfort.
- Daily treatment of mature body skin supports demand once shoppers accept a dedicated visible-texture step beyond general moisturizers.
- Brevintel analysis expects proof, tolerability, and reorder convenience—not catalog novelty—to decide whether $829M demand compounds toward $1.4B by 2036 at 5.6%.
Country growth spread, MoCRA, and launch economics
- The UAE is projected to outpace the USA by one percentage point through 2036 because premium discovery is concentrated in fewer retail hubs.
- Crepey skin treatment demand in the UAE is predicted to advance at 7.0% CAGR through 2036 versus 6.0% in the USA.
- Faster UAE growth does not imply a larger current revenue pool.
- FDA data through June 30, 2026 listed 1,298,361 active cosmetic product listings under MoCRA.
- Annual updates and ingredient records make broad USA portfolios more administrative.
- UAE and South Korea form the upper tier with Saudi Arabia close behind; USA, France and Germany occupy the middle; UK and Japan advance more slowly.
- Similar CAGRs therefore produce different launch economics and evidence burdens across regions.
- Country-level CAGR analysis spans North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa through 2036.
Market Dynamics
Drivers
- Daily treatment of mature body skin supports demand as shoppers extend visible-texture care beyond the face to neck and body zones.
- UN DESA’s February 2026 count of 1.22 billion people aged 60 or older worldwide expands the addressable mature-skin audience.
- Core - classic lines are estimated to hold 33.0% of product type demand in 2026 owing to broad routine fit and familiar use with lower switching friction.
- Shiseido renewed ULTIMUNE in March 2025 within its established skin-aging care program, absorbing treatment science without a separate regimen.
- Kao introduced SENSAI TOTAL FORM EXPERT CREAM in July 2025 for September rollout in more than 40 countries, keeping neck-inclusive firmness positioning relevant.
- Procter & Gamble launched Olay Super Serum Body Wash in February 2025 with serum-inspired ingredients, extending treatment language into accessible daily cleansing.
- Beiersdorf disclosed in March 2026 that its 2025 program included fragrance-free Eucerin firming care for mature dry skin.
- E-commerce & DTC at 31.0% in 2026 lets brands explain application zones and replenish in one purchase path.
Restraints and opportunities
- Claim and irritation limits restrain stronger formulas when body-area use raises sensitivity risk versus facial-only routines.
- Body-specific testing can widen repeat purchasing when shoppers feel a distinct visible-texture job rather than another interchangeable anti-aging cream.
- Mass is projected to hold 36.0% of price-positioning demand in 2026 owing to lower per-use cost across arms and neck plus chest and legs during sustained daily application.
- Premium tiers can justify higher prices with stronger testing or differentiated actives, yet large pack consumption places a practical ceiling on routine spending.
- Specialist nature claims can strengthen differentiation, though tighter ingredient or sourcing constraints may narrow texture choices during stability and sensory work.
- Serums signal concentrated actives, but cream & balm at 30.0% share in 2026 gives formulators more room to balance treatment ingredients with cushioning feel for dry mature skin.
- Physical beauty and pharmacy channels retain an advantage for guided selection, whereas digital merchandising gives body-specific texture concerns more explanatory space.
- Brevintel analysis treats body-specific proof and comfort—not broader anti-aging slogans—as the main path from trial to replenishment through 2036.
Segmentation Analysis
Product type
- The crepey skin treatments market is segmented by product type, nature, format, price positioning, and sales channel.
- Product type includes core - classic lines, targeted treatment lines, sensitive & gentle lines, premium & clinical lines, and kits & sets.
- Core - classic lines are estimated to hold 33.0% of product type demand in 2026 owing to broad routine fit and familiar use with lower switching friction.
- Familiar franchises reduce trial risk for shoppers using anti-aging creams for visible texture.
- Shiseido renewed ULTIMUNE in March 2025 within its established skin-aging care program.
- Long-running lines can absorb treatment science without requiring consumers to adopt a separate regimen.
- Long-running franchises can extend validated actives into neck or body care after tolerability testing, giving retailers a clearer replenishment story.
- Targeted treatment, sensitive & gentle, premium & clinical, and kits & sets compete where shoppers already accept a dedicated visible-texture step.
Nature
- Nature covers conventional, vegan & cruelty-free, natural & organic, dermocosmetic - clinical, and fragrance-free & sensitive.
- Conventional is forecast to represent 52.0% of nature demand in 2026 due to formulation flexibility and broad availability across mass and prestige price points.
- Conventional formulas give developers wider latitude in cosmetic chemicals selection for humectants and preservation.
- Beiersdorf disclosed in March 2026 that its 2025 program included fragrance-free Eucerin firming care for mature dry skin.
- Mainstream formulation platforms can address sensitivity without making a natural claim central.
- Specialist nature claims can strengthen differentiation on crowded shelves.
- Tighter ingredient or sourcing constraints may narrow texture choices during stability and sensory work.
- Dermocosmetic - clinical and fragrance-free & sensitive lines remain relevant where pharmacy advice or tolerability screens body-area use.
Format
- Format includes cream & balm, liquid & serum, stick & solid, spray & mist, sheet & patch, and powder.
- In 2026, cream & balm is expected to lead format with 30.0% share because spreadability and moisture retention support regular neck and body application.
- Cream and balm formats suit body firming creams because they cover dry areas without facial-dose economics.
- Kao introduced SENSAI TOTAL FORM EXPERT CREAM in July 2025 for September rollout in more than 40 countries.
- Neck-inclusive use and firmness positioning keep creams relevant to routines requiring spreadability and moisture.
- Serums signal concentrated actives, but creams give formulators more room to balance treatment ingredients with the cushioning feel needed by dry mature skin.
- Stick & solid, spray & mist, sheet & patch, and powder remain secondary formats for targeted or on-the-go use.
- Brevintel analysis expects format leadership to follow handling on larger body areas, not serum prestige cues alone, through 2036.
Price positioning
- Price positioning includes mass, masstige, premium, and professional.
- Mass is projected to hold 36.0% of price-positioning demand in 2026 owing to lower per-use cost across arms and neck plus chest and legs during sustained daily application.
- Body-area treatment consumes more product than facial-only routines, so price directly affects regimen continuity in anti-aging skincare.
- Procter & Gamble launched Olay Super Serum Body Wash in February 2025 with serum-inspired ingredients, extending treatment language into an accessible daily cleansing format.
- Premium tiers can justify higher prices with stronger testing or differentiated actives.
- Large pack consumption places a practical ceiling on routine spending over time.
- Masstige and professional tiers sit between accessible replenishment and clinic-adjacent advice.
- Brevintel analysis treats price as a replenishment constraint because body-area treatment raises unit consumption versus facial care alone.
Sales channel
- Sales channels cover e-commerce & DTC, specialty beauty retail, pharmacies & drugstores, supermarkets & hypermarkets, and salons & spas.
- E-commerce & DTC is likely to capture 31.0% of sales-channel demand in 2026 because education and replenishment can occur in one purchase path.
- Digital channels give brands enough space to explain application zones beside broader skincare routines.
- Coty reported in February 2025 that e-commerce represented about 20% of company sales.
- Online sell-out grew by double digits in prestige and consumer beauty during the first half.
- Physical beauty and pharmacy channels retain an advantage for guided selection.
- Digital merchandising gives body-specific texture concerns more explanatory space than a crowded shelf or short pack panel.
- Specialty beauty retail, pharmacies & drugstores, supermarkets & hypermarkets, and salons & spas remain important where advice, convenience, or professional application supports trial.
Regional Outlook
Country growth tiers
- UAE and South Korea form the upper tier with Saudi Arabia close behind.
- USA, France and Germany occupy the middle.
- UK and Japan advance more slowly through mature beauty channels.
- The UAE’s concentrated premium retail landscape accelerates consumer discovery and trial of advanced treatment products.
- South Korea’s fast-moving beauty market rapidly adopts and evaluates new treatment concepts and formats.
- Saudi Arabia rewards suppliers that enter the market with well-prepared import, registration, and launch strategies.
- The USA’s market scale increases the cost and complexity of building awareness for niche treatment categories.
- Similar CAGRs therefore produce different launch economics and evidence burdens through 2036.
USA, Germany, and France
- In the USA, large retailers and direct channels give body-texture treatments national reach, while crowded digital shelves make a narrow treatment purpose expensive to explain.
- USA Census Bureau data published in June 2025 put the population aged 65 or older at 61.2 million in 2024, establishing a large mature-skin user pool.
- Crepey skin treatment demand in the USA is forecast to rise at 6.0% CAGR over the forecast period, tied to scale in age-focused skin care and broad retail access.
- In Germany, pharmacies remain a trusted route for mature-skin formulas among consumers who expect restrained efficacy language and repeat-use comfort.
- Germany's crepey skin treatments outlook is anticipated to advance at 5.4% CAGR over the assessment period, owing to an older consumer base and established pharmacy demand.
- Destatis stated in June 2026 that people aged 60 or older represented 31% of Germany's population after increasing during 2025.
- Insee's January 2026 demographic report put people aged 65 or older at 22% of France's population at year start, confirming a sizeable mature consumer base.
- France is projected to grow at 5.7% CAGR through 2036, aided by established interest in efficacy-led age care and specialist recommendation.
United Kingdom, Saudi Arabia, and the UAE
- Great Britain offers broad pharmacy and online access at national scale, but cosmetics follow a notification route separate from the EU system.
- GOV.UK guidance published in July 2025 requires a named Responsible Person and OPSS notification before a cosmetic product reaches consumers in Great Britain.
- Adoption of crepey skin treatments in the UK is estimated to expand at 5.0% CAGR through 2036, given mature skin-care use and broad channel coverage.
- SFDA's cosmetic notification page was updated in March 2025 and gives importers a defined documentation path for products entering the Saudi system.
- The Saudi Arabia crepey skin treatments sector is projected to record 6.3% CAGR during the assessment period, reinforced by wider access to premium treatment formats.
- Arabic-ready communication and complete product files are commercially important because clearance delays can erase seasonal retail windows.
- Crepey skin treatment demand in the UAE is predicted to advance at 7.0% CAGR through 2036, attributable to concentrated premium retail and digital product discovery.
- Dubai Municipality described Montaji in May 2025 as its smart platform for registering consumer products before local marketing for local sale.
Japan and South Korea
- Long experience with age-care routines shapes Japanese consumer expectations, with particular attention to comfortable texture on the neck and body.
- Statistics Bureau data released in April 2025 put people aged 65 or older at 29.3% of the population, giving mature-skin care a large addressable base.
- Japan is estimated to post 4.7% CAGR over the forecast period, shaped by mature-skin needs inside a highly developed beauty category.
- Stronger wrinkle positioning can enter the quasi-drug route, so companies linking hyaluronic acid care with body treatment must plan local claims before launch.
- Performance-led skin care benefits from a familiar regulatory route in South Korea, where wrinkle-improvement claims can enter the functional-cosmetic system.
- MFDS amended its functional-cosmetics review rules in December 2025 and expanded selected submission exemptions for solid dosage forms used in qualifying wrinkle claims.
- Crepey skin treatment sales in South Korea are forecast to expand at 6.7% CAGR by 2036, propelled by fast product renewal and high treatment literacy.
- Companies linking K-beauty products with body care still need claim classification settled before export preparation, since rapid launch cycles quickly punish late evidence changes.
Competitive Landscape
Franchise fit versus body-specific proof
- Shiseido, Kao Corporation, Unilever, Procter & Gamble, Amorepacific, L'Oreal, Coty, e.l.f. Beauty, Beiersdorf, and Estee Lauder Companies are notable companies serving this market.
- Competition turns on whether a visible-texture treatment can sit beside a known anti-aging franchise without looking like a duplicate moisturizer.
- Shiseido’s March 2025 ULTIMUNE renewal keeps classic skin-aging care current for shoppers who already trust the line.
- Kao’s July 2025 SENSAI TOTAL FORM EXPERT CREAM rollout links neck-inclusive firmness positioning with international distribution in more than 40 countries.
- Procter & Gamble’s February 2025 Olay Super Serum Body Wash launch extends treatment language into accessible daily cleansing at mass price points.
- Beiersdorf’s March 2026 disclosure of fragrance-free Eucerin firming care for mature dry skin shows mainstream platforms can address sensitivity without a natural claim.
- Coty’s February 2025 disclosure that e-commerce was about 20% of sales, with double-digit online sell-out, shows digital education capacity inside a global beauty portfolio.
- Brevintel analysis expects share to follow proof, tolerability, and reorder economics as the market moves from USD 829.2 million ($829M) in 2026 toward USD 1,429.9 million ($1.4B) by 2036 at 5.6%.
Integrated producers
- L'Oreal
- Procter & Gamble
- Unilever
- Beiersdorf
- Estee Lauder Companies
- Coty
Specialty suppliers
- Shiseido
- Kao Corporation
- Amorepacific
- e.l.f. Beauty